SEC Filing Summary: Ra Medical Systems, Inc. (RMED)
Business Context and Reporting Period
This Form 8-K was filed by Ra Medical Systems, Inc. on August 17, 2022, reporting events that occurred on August 16, 2022. The Company is incorporated in Delaware and trades on the NYSE American under the symbol RMED. The filing addresses corporate governance amendments rather than operational or financial performance updates.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current report regarding bylaw amendments and does not contain financial statements or performance data.
Material Changes
The Board of Directors amended the Company's Amended and Restated Bylaws effective immediately. The material changes include:
- Quorum Reduction: Section 2.6 was amended to reduce the quorum required to hold stockholder meetings from a majority of the voting power of stock issued and outstanding to a lower threshold (specific new percentage not detailed in the summary text, only the reduction is noted).
- Voting Threshold Adjustment: Section 2.9 was amended to change the voting threshold for all matters other than the election of directors. The new standard requires the affirmative vote of a majority of the voting power of shares present in person or by proxy and casting votes affirmatively or negatively.
Guidance, Outlook, and Risks
The filing contains no management commentary regarding financial guidance, future outlook, specific risks, contingencies, or unusual items. The document is strictly procedural regarding the Bylaws Amendment.
Key Facts for Investor Verification
- Verify the specific new quorum percentage in the full text of Exhibit 3.1 (Bylaws Amendment) as the summary text only confirms a reduction.
- Confirm the impact of the new voting threshold on future shareholder proposals and director elections.
- Note that this filing does not reflect any change in the Company's financial position or operational strategy.